Adherence

MedAvail Announces Continued Expansion of Its Technology Agreement With a North Texas Health System

Retrieved on: 
Wednesday, April 14, 2021
Health, Technology, Hospitals, Practice Management, Software, General Health, Pharmaceutical, Health sciences, Health, Health care quality, Medicinal chemistry, Pharmacy, Symbols, Adherence

Through MedAvail\xe2\x80\x99s Pharmacy Technology segment, the company is able to enhance pharmacy services offered by healthcare providers and retail chains.

Key Points: 
  • Through MedAvail\xe2\x80\x99s Pharmacy Technology segment, the company is able to enhance pharmacy services offered by healthcare providers and retail chains.
  • Enterprise customers can purchase MedAvail\xe2\x80\x99s technology in order to provide these solutions under their own brands.\n\xe2\x80\x9cWe are proud to offer our software and MedCenter technology to large healthcare systems focused on medication adherence and patient satisfaction,\xe2\x80\x9d said Dave Rawlins, Chief Commercial Officer at MedAvail.
  • \xe2\x80\x9cQuick and convenient access to care is even more critical now than ever.
  • MedAvail helps patients to optimize drug adherence, resulting in better health outcomes.

Study affirms oral disease-modifying therapies are well tolerated with high medication adherence rates

Retrieved on: 
Thursday, April 15, 2021
Health sciences, Medicine, Health, Adherence, Clinical pharmacology, Health care quality, Medical terminology, Pharmacy, Multiple sclerosis

b'ORLANDO, Fla., April 15, 2021 /PRNewswire/ --A recent study of patients receiving oral FDA-approved therapies used to treat relapsing forms of multiple sclerosis (MS) revealed high tolerance, low rates of adverse drug events, and similar medication adherence rates across all study medications.

Key Points: 
  • b'ORLANDO, Fla., April 15, 2021 /PRNewswire/ --A recent study of patients receiving oral FDA-approved therapies used to treat relapsing forms of multiple sclerosis (MS) revealed high tolerance, low rates of adverse drug events, and similar medication adherence rates across all study medications.
  • The study found no statistically significant difference in medication adherence as measured by Proportion of Days Covered (PDC) based upon the presence or absence of a patient-reported ADE.
  • This may be an indication oral DMTs are well tolerated from an ADE perspective," he says.
  • "Patients may realize these types of therapies are generally well tolerated and have good rates of medication adherence which may help delay MS disease progression," he says.

Drive-through or Home Visit, PPOA Has You Covered for COVID-19 testing

Retrieved on: 
Thursday, April 8, 2021
Medicine, Health sciences, Health, Ppoa, Health care quality, Patient, Adherence, Doctor–patient relationship

Whether one wants concierge service or to drive up and go, PPOA offer excellent options for rapid test results.

Key Points: 
  • Whether one wants concierge service or to drive up and go, PPOA offer excellent options for rapid test results.
  • "Since our drive-through site opened, about 5,000 people have taken advantage of the service," said Rekha Rajan-Wilson, PPOA Vice President of Compliance and Risk.
  • "PPOA is honored to be able to serve our community with this added service."
  • Physician Partners of America (PPOA) is a national healthcare organization focused on strengthening the doctor-patient relationship and improving patient outcomes.

Tabula Rasa HealthCare Partners with athenahealth's Marketplace Program to Provide Medication Decision Support Tools

Retrieved on: 
Thursday, April 8, 2021
Health sciences, Health, Pharmacy, Health care quality, Medical terminology, Adherence, Clinical pharmacology, Pharmacist

MedWise medication decision support tools identify simultaneous, accumulative, multi-drug interactions, enabling providers to improve medication safety, efficacy, and adherence.

Key Points: 
  • MedWise medication decision support tools identify simultaneous, accumulative, multi-drug interactions, enabling providers to improve medication safety, efficacy, and adherence.
  • "Our unique medication safety platform, MedWise, helps pharmacists to optimize medication regimens by calculating patients' MedWise Risk Scores."
  • Tabula Rasa HealthCare (TRHC) provides medication safety solutions that empower healthcare professionals to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events.
  • Through its proprietary medication decision science technology, MedWise, TRHC improves patient outcomes, reduces hospitalizations, and lowers healthcare costs.

HCCA Celebrates the Release of an All-New Complete Healthcare Compliance Manual

Retrieved on: 
Tuesday, April 6, 2021
Health sciences, Health, Adherence, Clinical pharmacology, Health care quality, Medical terminology, Pharmacy, Regulatory compliance, Chief compliance officer, Frank E. Sheeder III

MINNEAPOLIS, April 6, 2021 /PRNewswire/ --Health Care Compliance Association (HCCA) is pleased to announce the release of the Complete Healthcare Compliance Manual, a comprehensive guide written by compliance professionals for compliance professionals.

Key Points: 
  • MINNEAPOLIS, April 6, 2021 /PRNewswire/ --Health Care Compliance Association (HCCA) is pleased to announce the release of the Complete Healthcare Compliance Manual, a comprehensive guide written by compliance professionals for compliance professionals.
  • The Complete Healthcare Compliance Manual will be available for purchase with a variety of pricing options starting at $199 for HCCA members and $249 for non-members.
  • To purchase an online subscription or pre-order a print copy, visit www.hcca-info.org/CHCM
    Health Care Compliance Association (HCCA) is a non-profit professional membership organization for healthcare compliance professionals.
  • Since 1996, HCCA has been championing ethical practices and compliance standards to promote lasting success and integrity of healthcare organizations.

Vytal Launches to Offer Consumers Frictionless Prescription Management and Delivery

Retrieved on: 
Tuesday, April 6, 2021
Health sciences, Health, Health care quality, Adherence, Clinical pharmacology, Medical terminology, Pharmacy, Personalized marketing

Every year, non-adherence leads to illnesses, death, and costs the U.S. health system as much as $528 billion .

Key Points: 
  • Every year, non-adherence leads to illnesses, death, and costs the U.S. health system as much as $528 billion .
  • VytalOS also provides manufacturers an engaging web experience to offer their products online for delivery directly to patients.
  • Vytal also works with partners to create personalized marketing and custom packaging to provide an engaging patient experience.
  • Vytal takes care of the administration work needed to prescribe and manage orders, such as billing and is able to communicate directly with patients.

Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and Sensor-Based Technologies

Retrieved on: 
Tuesday, April 6, 2021
Mental health, Technology, Medical devices, Software, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Consumer electronics, Articles, Health, Health informatics, Biomarker, Cell biology, Digital therapeutics, Digital pill, Machine learning, Adherence, Educational technology

These new agreements bolster Pears Prescription Digital Therapeutics (PDT) platform, by adding to its library of digital biomarkers, machine learning algorithms, sensor-based technologies, and digital therapeutics.

Key Points: 
  • These new agreements bolster Pears Prescription Digital Therapeutics (PDT) platform, by adding to its library of digital biomarkers, machine learning algorithms, sensor-based technologies, and digital therapeutics.
  • Pear has built the first scalable platform infrastructure to discover, develop, and deliver PDTs to patients.
  • Pear is collaborating with etectRx, Inc., an innovator in medication adherence technology, to explore the development of digital therapeutics combined with digital pills.
  • In 2020, Pear licensed from Winterlight Labs machine learning-based voice digital biomarkers that analyze and assess cognitive health.

RxCap Featured in Clinical Study of Stroke Patients, Complete Findings Published in Frontiers of Neurology

Retrieved on: 
Monday, April 5, 2021
Health, Rehabilitation medicine, Health care quality, Telerehabilitation, Adherence

The study, "A Feasibility Study of Expanded Home-Based Telerehabilitation After Stroke," was led by Dr. Steven C. Cramer, Professor of Neurology at University of California Los Angeles and published in Frontiers of Neurology https://www.frontiersin.org/articles/10.3389/fneur.2020.611453/full .

Key Points: 
  • The study, "A Feasibility Study of Expanded Home-Based Telerehabilitation After Stroke," was led by Dr. Steven C. Cramer, Professor of Neurology at University of California Los Angeles and published in Frontiers of Neurology https://www.frontiersin.org/articles/10.3389/fneur.2020.611453/full .
  • The UCLA research team connected the RxCap technology within the study with the hope that patients were able to utilize the platform despite their respective mobility impairments.
  • "RxCap was easy to use, set-up and implement in our study which meant minimal training for our clinical study research staff and patients," said Dr. Cramer.
  • "This study demonstrates that RxCap is highly effective in patient-centric clinical research as both a data capture and adherence support system improving patient outcomes.

Omnicell to Release First Quarter 2021 Financial Results on April 29, 2021

Retrieved on: 
Thursday, April 1, 2021
Data management, Health, Technology, Practice Management, Software, Pharmaceutical, Health sciences, Health, Medicinal chemistry, Pharmacy, Symbols, Adherence

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter of 2021 after the close of the market on Thursday, April 29, 2021.

Key Points: 
  • Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter of 2021 after the close of the market on Thursday, April 29, 2021.
  • The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m.
  • Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs.
  • Omnicell and the Omnicell logo are registered trademarks of Omnicell, Inc. in the United States and other countries.

emocha Announces Results from video Directly Observed Therapy Study with Alameda County, California's TB Program

Retrieved on: 
Tuesday, March 23, 2021
Tuberculosis, Medicine, Health sciences, Health, Tuberculosis management, Adherence, TB Alert, National TB Elimination Program

The Alameda County Health Department implemented video DOT, beginning with a pilot in 2017, to increase flexibility and meet patient-specific needs.

Key Points: 
  • The Alameda County Health Department implemented video DOT, beginning with a pilot in 2017, to increase flexibility and meet patient-specific needs.
  • 94 patients out of 163 -- all of whom were confirmed TB patients -- total received video DOT, with more than half exclusively using video DOT.
  • These results indicate that a busy urban TB program was able to successfully implement a video DOT program that achieved higher rates of medication verification that in person DOT.
  • "Video DOT provides Alameda County TB patients and the TB program with a patient-centered option for ensuring adherence, monitoring, and engagement with patients throughout treatment," says Dr. Amit Chitnis, Tuberculosis Controller and Section Director at Alameda County Public Health Department, TB Section.